← Back to headlines
Wave Stock Hits 52-Week Low Following Obesity Drug Data Reaction
Wave's stock has fallen to a 52-week low as analysts react to new data concerning the company's obesity drug.
26 Mar, 18:38 — 26 Mar, 18:38
Sources
Showing 1 of 1 sources
Related Stories
Chernobyl Reactor Damage from Russian Attack Hinders Radiation Containment
19m ago
EMA Accepts Nuvation Bio and Eisai's Taletrectinib Application for NSCLC
33m ago
Iran's IRGC Claims Control, Advocates Nuclear Policy Shift After Khamenei's Death
41m ago
The Science Behind March Madness: Why Our Brains Love Brackets
57m ago